F-group (family)
2003.1.1.51 DFP
Ligands and drugs
170
Member domains
61
with ligand contacts (≤ 4 Å)
35.9% of members
41
with DrugDomain annotations
24.1% of members
32
with a DrugBank compound
18.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.1.51 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02431 | CTP | Cytidine-5'-Triphosphate | 17 |
| DB03403 | C5P | Cytidine-5'-Monophosphate | 3 |
| DB16966 | PAZ | Phosphopantothenic acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CTP | CYTIDINE-5'-TRIPHOSPHATE | 37 |
| CAmetal | CALCIUM ION | 30 |
| MGmetal | MAGNESIUM ION | 7 |
| PMT | PHOSPHORIC ACID MONO-[3-(3-{[5-(4-AMINO-2-OXO-2H-PYRIMIDIN-1-YL)-3,4- DIHYDROXY-TETRAHYDRO-FURAN-2- YLMETHOXY]-HYDROXY-PHOSPHORYLOXY}-3-OXO-PROPYLCARBAMOYL)-3-HYDROXY-2,2- DIMETHYL-PROPYL] ESTER | 5 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 4 |
| J1O | 4-[[(2R)-3,3-dimethyl-2-oxidanyl-4-phosphonooxy-butanoyl]amino]butanoic acid | 4 |
| N9N | (4-hydroxyphenyl)-[2,3,4-tris(oxidanyl)phenyl]methanone | 4 |
| W4X | 2-[1-[3,4-bis(oxidanyl)phenyl]-5-phenyl-indol-3-yl]-2-oxidanylidene-ethanoic acid | 4 |
| C5P | CYTIDINE-5'-MONOPHOSPHATE | 3 |
| W52 | 2-[1-(4-hydroxyphenyl)-5-phenyl-indol-3-yl]-2-oxidanylidene-ethanoic acid | 3 |
| 9Z3 | N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl-L-cysteine | 2 |
| 9Z6 | (5R,12R,17R)-17-amino-12-carboxy-1,1,5-trihydroxy-4,4-dimethyl-6,10-dioxo-2-oxa-14,15-dithia-7,11-diaza-1-phosphaoctadecan-18-oic acid 1-oxide (non-preferred name) | 2 |
| PAZ | N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanine | 2 |
| VE6 | 2-[5-bromanyl-1-(4-hydroxyphenyl)indol-3-yl]-2-oxidanylidene-ethanoic acid | 2 |
| VEO | 5-methoxy-1H-indole-2-carboxylic acid | 2 |
| W5E | 2-[1-[3,4-bis(oxidanyl)phenyl]-5-(3-hydroxyphenyl)indol-3-yl]-2-oxidanylidene-ethanoic acid | 2 |